Table 4 The frequency of abnormal components in MetS subjects
| Â | Male MetS subjects | Â | Female MetS subjects | Â | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Disorders | 18–45 (n = 203) | 46–55 (n = 339) | 56–65 (n = 355) | > 65 (n = 273) | P value | 18–45 (n = 181) | 46–55 (n = 460) | 56–65 (n = 715) | > 65 (n = 542) | P value |
WC, n (%) | 135(66.5) | 242(71.4) | 246(69.3) | 193(70.7) | 0.828 | 138(76.2) | 387(84.1) | 604(84.5) | 467(86.2) | 0.61 |
FBG, n (%) | 109(53.7) | 242(71.4) | 271(76.3) | 206(75.5) | 0.29 | 90(49.7) | 264(57.4) | 464(64.9) | 380(70.1) | < 0.001 |
TG, n (%) | 192(94.6) | 297(87.6) | 274(77.2) | 182(66.7) | < 0.001 | 116(64.1) | 300(65.2) | 495(69.2) | 310(57.2) | < 0.001 |
HDL, n (%) | 67(33.0) | 85(25.1) | 89(25.1) | 66(24.2) | 0.959 | 144(79.6) | 288(62.6) | 386(54.0) | 282(52.0) | 0.002 |
BP, n (%) | 182(89.7) | 298(87.9) | 329(92.7) | 266(97.4) | < 0.001 | 136(75.1) | 384(83.5) | 632(88.4) | 521(96.1) | < 0.001 |
Z-score | 1.40(−0.05,3.27) | 1.31(−0.00,3.63) | 1.11(−0.37,2.85) a | 0.88(−0.29,2.60) # |  | 0.96(−0.15,2.81) | 1.35(0.08,3.34) | 1.70(0.22,3.60) | 2.03(0.58,3.80)a |  |